Works matching IS 15228517 AND DT 2021 AND VI 23 AND IP 8

Results: 31

Highlights from the Literature.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1228, doi. 10.1093/neuonc/noab149
Publication type:
Article
Forthcoming Meetings.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1416, doi. 10.1093/neuonc/noab148
Publication type:
Article
Especially for neuro-oncologists—minimally important differences for the EORTC QLQ-C30 in glioma patients.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1222, doi. 10.1093/neuonc/noab124
By:
- Mendoza, Tito R
Publication type:
Article
Protons for the management of adult patients with glioblastoma.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1223, doi. 10.1093/neuonc/noab121
By:
- Laperriere, Normand J
Publication type:
Article
The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1215, doi. 10.1093/neuonc/noab120
By:
- Wen, Patrick Y;
- Packer, Roger J
Publication type:
Article
Neurocognitive functions in primary CNS lymphoma.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1220, doi. 10.1093/neuonc/noab113
By:
- Correa, Denise D
Publication type:
Article
Reply to letter by Schwartz et al.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1406, doi. 10.1093/neuonc/noab078
By:
- Kuksis, Markus;
- Gao, Yizhuo;
- Kiss, Alex;
- Jerzak, Katarzyna J
Publication type:
Article
Converging evidence for inhibition of transcriptional control in high-grade gliomas.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1225, doi. 10.1093/neuonc/noab112
By:
- Dahl, Nathan A;
- Vibhakar, Rajeev
Publication type:
Article
Reply to the letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients—a report of the PET/RANO group": 18F-fluciclovine and target volume delineation.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1410, doi. 10.1093/neuonc/noab098
By:
- Galldiks, Norbert;
- Niyazi, Maximilian;
- Tonn, Jörg-Christian;
- Langen, Karl-Josef
Publication type:
Article
Letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients—a report of the PET/RANO group": 18F-fluciclovine and target volume delineation.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1408, doi. 10.1093/neuonc/noab097
By:
- Kotecha, Rupesh;
- Aboian, Mariam;
- Nabavizadeh, Seyed Ali;
- Parent, Ephraim E;
- Trifiletti, Daniel M;
- Chao, Samuel T
Publication type:
Article
Prognostication for meningiomas: H3K27me3 to the rescue?
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1218, doi. 10.1093/neuonc/noab083
By:
- Santagata, Sandro;
- Ligon, Keith L
Publication type:
Article
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1252, doi. 10.1093/neuonc/noab082
By:
- Lee, Eudocia Q;
- Selig, Wendy;
- Meehan, Clair;
- Bacha, Jeffrey;
- Barone, Amy;
- Bloomquist, Erik;
- Chang, Susan M;
- Groot, John F de;
- Galanis, Evanthia;
- Hassan, Islam;
- Kalidas, Chitkala;
- Khasraw, Mustafa;
- Kvedar, Joseph C;
- Lassman, Andrew B;
- Puduvalli, Vinay;
- Sahebjam, Solmaz;
- Schwamm, Lee H;
- Tamir, Sharon;
- Welch, Mary;
- Yung, W K Alfred
Publication type:
Article
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1231, doi. 10.1093/neuonc/noab106
By:
- Louis, David N;
- Perry, Arie;
- Wesseling, Pieter;
- Brat, Daniel J;
- Cree, Ian A;
- Figarella-Branger, Dominique;
- Hawkins, Cynthia;
- Ng, H K;
- Pfister, Stefan M;
- Reifenberger, Guido;
- Soffietti, Riccardo;
- Deimling, Andreas von;
- Ellison, David W
Publication type:
Article
The incidence of major subtypes of primary brain tumors in adults in England 1995-2017.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1371, doi. 10.1093/neuonc/noab076
By:
- Wanis, Hiba A;
- Møller, Henrik;
- Ashkan, Keyoumars;
- Davies, Elizabeth A
Publication type:
Article
Letter to the editor concerning Kuksis et al.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1404, doi. 10.1093/neuonc/noab050
By:
- Schwartz, Naomi R M;
- Dalmat, Ronit R
Publication type:
Article
Loss of H3K27me3 in meningiomas.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1282, doi. 10.1093/neuonc/noab036
By:
- Nassiri, Farshad;
- Wang, Justin Z;
- Singh, Olivia;
- Karimi, Shirin;
- Dalcourt, Tatyana;
- Ijad, Nazanin;
- Pirouzmand, Neda;
- Ng, Ho-Keung;
- Saladino, Andrea;
- Pollo, Bianca;
- Dimeco, Francesco;
- Yip, Stephen;
- Gao, Andrew;
- Aldape, Kenneth D;
- Zadeh, Gelareh;
- Meningiomas, The International Consortium on
Publication type:
Article
Longitudinal change in fine motor skills after brain radiotherapy and in vivo imaging biomarkers associated with decline.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1393, doi. 10.1093/neuonc/noab017
By:
- Salans, Mia;
- Tibbs, Michelle D;
- Karunamuni, Roshan;
- Yip, Anthony;
- Huynh-Le, Minh-Phuong;
- Macari, Anna Christina;
- Reyes, Anny;
- Tringale, Kathryn;
- McDonald, Carrie R;
- Hattangadi-Gluth, Jona A
Publication type:
Article
Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1348, doi. 10.1093/neuonc/noab009
By:
- Katagi, Hiroaki;
- Takata, Nozomu;
- Aoi, Yuki;
- Zhang, Yongzhan;
- Rendleman, Emily J;
- Blyth, Gavin T;
- Eckerdt, Frank D;
- Tomita, Yusuke;
- Sasaki, Takahiro;
- Saratsis, Amanda M;
- Kondo, Akihide;
- Goldman, Stewart;
- Becher, Oren J;
- Smith, Edwin;
- Zou, Lihua;
- Shilatifard, Ali;
- Hashizume, Rintaro
Publication type:
Article
H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1273, doi. 10.1093/neuonc/noaa303
By:
- Behling, Felix;
- Fodi, Christina;
- Gepfner-Tuma, Irina;
- Kaltenbach, Kristina;
- Renovanz, Mirjam;
- Paulsen, Frank;
- Skardelly, Marco;
- Honegger, Jürgen;
- Tatagiba, Marcos;
- Meningiomas, International Consortium on;
- Schittenhelm, Jens;
- Tabatabai, Ghazaleh
Publication type:
Article
Partitioned glioma heritability shows subtype-specific enrichment in immune cells.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1304, doi. 10.1093/neuonc/noab072
By:
- Ostrom, Quinn T;
- Edelson, Jacob;
- Byun, Jinyoung;
- Han, Younghun;
- Kinnersley, Ben;
- Melin, Beatrice;
- Houlston, Richard S;
- Monje, Michelle;
- Consortium, GLIOGENE;
- Walsh, Kyle M;
- Amos, Christopher I;
- Bondy, Melissa L
Publication type:
Article
Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1415, doi. 10.1093/neuonc/noaa115
By:
- van den Bent, Martin;
- Eoli, Marica;
- Sepulveda, Juan Manuel;
- Smits, Marion;
- Walenkamp, Annemiek;
- Frenel, Jean-Sebastian;
- Franceschi, Enrico;
- Clement, Paul M;
- Chinot, Olivier;
- Vos, Filip de;
- Whenham, Nicolas;
- Sanghera, Paul;
- Weller, Michael;
- Dubbink, H J;
- French, Pim;
- Looman, Jim;
- Dey, Jyotirmoy;
- Krause, Scott;
- Ansell, Pete;
- Nuyens, Sarah
Publication type:
Article
Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjects.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1383, doi. 10.1093/neuonc/noab049
By:
- Tschernichovsky, Roi;
- Katz, Lior H;
- Derazne, Estela;
- Berliner, Matan Ben-Zion;
- Simchoni, Maya;
- Levine, Hagai;
- Keinan-Boker, Lital;
- Benouaich-Amiel, Alexandra;
- Kanner, Andrew A;
- Laviv, Yosef;
- Honig, Asaf;
- Dudnik, Elizabeth;
- Siegal, Tali;
- Mandel, Jacob;
- Twig, Gilad;
- Yust-Katz, Shlomit
Publication type:
Article
The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysis.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1261, doi. 10.1093/neuonc/noab046
By:
- Jessurun, Charissa A C;
- Hulsbergen, Alexander F C;
- Wit, Anouk E de;
- Tewarie, Ishaan A;
- Snijders, Tom J;
- Verhoeff, Joost J C;
- Phillips, John G;
- Reardon, David A;
- Mekary, Rania A;
- Broekman, Marike L D
Publication type:
Article
DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1292, doi. 10.1093/neuonc/noab044
By:
- Mosella, Maritza S;
- Sabedot, Thais S;
- Silva, Tiago C;
- Malta, Tathiane M;
- Dezem, Felipe Segato;
- Asmaro, Karam P;
- Wells, Michael;
- Mukherjee, Abir;
- Poisson, Laila M;
- Snyder, James;
- deCarvalho, Ana C;
- Walbert, Tobias;
- Aho, Todd;
- Kalkanis, Steven;
- Elias, Paula C;
- Antonini, Sonir R;
- Rock, Jack;
- Noushmehr, Houtan;
- Castro, Margaret;
- Castro, Ana Valeria
Publication type:
Article
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1337, doi. 10.1093/neuonc/noab040
By:
- Brown, Paul D;
- Chung, Caroline;
- Liu, Diane D;
- McAvoy, Sarah;
- Grosshans, David;
- Feghali, Karine Al;
- Mahajan, Anita;
- Li, Jing;
- McGovern, Susan L;
- McAleer, Mary-Fran;
- Ghia, Amol J;
- Sulman, Erik P;
- Penas-Prado, Marta;
- Groot, John F de;
- Heimberger, Amy B;
- Wang, Jihong;
- Armstrong, Terri S;
- Gilbert, Mark R;
- Guha-Thakurta, Nandita;
- Wefel, Jeffrey S
Publication type:
Article
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1327, doi. 10.1093/neuonc/noab037
By:
- Dirven, Linda;
- Musoro, Jammbe Z;
- Coens, Corneel;
- Reijneveld, Jaap C;
- Taphoorn, Martin J B;
- Boele, Florien W;
- Groenvold, Mogens;
- Bent, Martin J van den;
- Stupp, Roger;
- Velikova, Galina;
- Cocks, Kim;
- Sprangers, Mirjam A G;
- King, Madeleine T;
- Flechtner, Hans-Henning;
- Bottomley, Andrew
Publication type:
Article
Erratum to 'Connexin43 peptide, TAT-Cx43266–283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo'.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1414, doi. 10.1093/neuonc/noaa087
By:
- Jaraíz-Rodríguez, Myriam;
- Talaverón, Rocío;
- García-Vicente, Laura;
- Pelaz, Sara G;
- Domínguez-Prieto, Marta;
- Álvarez-Vázquez, Andrea;
- Flores-Hernández, Raquel;
- Sin, Wun Chey;
- Bechberger, John;
- Medina, José M;
- Naus, Christian C;
- Tabernero, Arantxa
Publication type:
Article
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1360, doi. 10.1093/neuonc/noab034
By:
- Baroni, Lorena V;
- Sundaresan, Lakshmikirupa;
- Heled, Ayala;
- Coltin, Hallie;
- Pajtler, Kristian W;
- Lin, Tong;
- Merchant, Thomas E;
- McLendon, Roger;
- Faria, Claudia;
- Buntine, Molly;
- White, Christine L;
- Pfister, Stefan M;
- Gilbert, Mark R;
- Armstrong, Terri S;
- Bouffet, Eric;
- Kumar, Sachin;
- Taylor, Michael D;
- Aldape, Kenneth D;
- Ellison, David W;
- Gottardo, Nicholas G
Publication type:
Article
Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1315, doi. 10.1093/neuonc/noab021
By:
- van der Meulen, Matthijs;
- Dirven, Linda;
- Habets, Esther J J;
- Bakunina, Katerina;
- Smits, Marion;
- Achterberg, Hakim C;
- Seute, Tatjana;
- Cull, Gavin;
- Schouten, Harry;
- Zijlstra, Josée M;
- Brandsma, Dieta;
- Enting, Roelien H;
- Beijert, Max;
- Taphoorn, Martin J B;
- Bent, Martin J van den;
- Issa, Samar;
- Doorduijn, Jeanette K;
- Bromberg, Jacoline E C
Publication type:
Article
Erratum: Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1413, doi. 10.1093/neuonc/noaa063
By:
- Comba, Andrea;
- Dunn, Patrick J;
- Argento, Anna E;
- Kadiyala, Padma;
- Ventosa, Maria;
- Patel, Priti;
- Zamler, Daniel B;
- Nunez, Felipe J;
- Zhao, Lili;
- Castro, Maria G;
- Lowenstein, Pedro R
Publication type:
Article
Corrigendum to Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.
Published in:
Neuro-Oncology, 2021, v. 23, n. 8, p. 1412, doi. 10.1093/neuonc/noaa005
Publication type:
Article

Works matching IS 15228517 AND DT 2021 AND VI 23 AND IP 8

Highlights from the Literature.

Forthcoming Meetings.

Especially for neuro-oncologists—minimally important differences for the EORTC QLQ-C30 in glioma patients.

Protons for the management of adult patients with glioblastoma.

The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications.

Neurocognitive functions in primary CNS lymphoma.

Reply to letter by Schwartz et al.

Converging evidence for inhibition of transcriptional control in high-grade gliomas.

Reply to the letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients—a report of the PET/RANO group": <sup>18</sup>F-fluciclovine and target volume delineation.

Letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients—a report of the PET/RANO group": <sup>18</sup>F-fluciclovine and target volume delineation.

Prognostication for meningiomas: H3K27me3 to the rescue?

Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

The incidence of major subtypes of primary brain tumors in adults in England 1995-2017.

Letter to the editor concerning Kuksis et al.

Loss of H3K27me3 in meningiomas.

Longitudinal change in fine motor skills after brain radiotherapy and in vivo imaging biomarkers associated with decline.

Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma.

H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort.

Partitioned glioma heritability shows subtype-specific enrichment in immune cells.

Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.

Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjects.

The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysis.

DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features.

A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.

Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients.

Erratum to 'Connexin43 peptide, TAT-Cx43<sub>266–283</sub>, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo'.

Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q.

Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial.

Erratum: Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses.

Corrigendum to Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.